Skip to the page

Data / Form D filings / Merlin Biotech, Inc.

Merlin Biotech, Inc.: Form D filing

Merlin Biotech, Inc., a biotechnology company in Doylestown, PA, filed a Form D with the SEC in 2026. The latest, on August 11, 2026, reports $50,000 sold of a $50,000 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3805 OLD EASTON ROAD, Doylestown, PA, 18901
Phone
(215) 589-6111
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2149714

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 11, 2026New notice$50,000$50,0002Jun 30, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Randall HyerExecutive Officer, Director
Carol BrosgartDirector
Jay BhatiaDirector
Loren DanzisDirector
Nikhil HebleExecutive Officer
Nick SpringExecutive Officer

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Aug 10, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Merlin Biotech, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.